| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| J M Tillema, A McKeo. The spectrum of neuromyelitis optica (NMO) in childhood. Journal of child neurology. vol 27. issue 11. 2013-04-04. PMID:22859697. |
the evaluation of inflammatory central nervous system disorders in childhood with predominant involvement of the optic nerves and spinal cord has been greatly enhanced over the last decade with identification of a group of disorders unified by the detection of neuromyelitis optica (nmo)-igg, an antibody targeting the central nervous system-predominant water channel aquaporin-4. |
2013-04-04 |
2023-08-12 |
Not clear |
| Kei Takayama, Akihiro Kojima, Takayuki Kanda, Masaru Takeuch. [A case of neuromyelitis optica presenting ileus as a neurologic finding]. Nippon Ganka Gakkai zasshi. vol 116. issue 10. 2013-04-04. PMID:23285844. |
to report an atypical case of neuromyelitis optica (nmo) with sjögren syndrome that presented only ileus as a neurologic finding. |
2013-04-04 |
2023-08-12 |
Not clear |
| J de Sez. Atypical forms of optic neuritis. Revue neurologique. vol 168. issue 10. 2013-04-03. PMID:22981300. |
in the first case, it corresponds to relapsing inflammatory optic neuritis (rion) and in the second case to neuromyelitis optica (nmo). |
2013-04-03 |
2023-08-12 |
Not clear |
| Lukmanee Tradtrantip, Julien Ratelade, Hua Zhang, A S Verkma. Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody. Annals of neurology. vol 73. issue 1. 2013-03-25. PMID:23055279. |
neuromyelitis optica (nmo) is caused by binding of pathogenic autoantibodies (nmo-immunoglobulin g [igg]) to aquaporin-4 (aqp4) on astrocytes, which initiates complement-dependent cytotoxicity (cdc) and inflammation. |
2013-03-25 |
2023-08-12 |
Not clear |
| Zhiye Chen, Feng Feng, Yang Yang, Jinfeng Li, Lin M. MR imaging findings of the corpus callosum region in the differentiation between multiple sclerosis and neuromyelitis optica. European journal of radiology. vol 81. issue 11. 2013-03-22. PMID:22445592. |
to evaluate mr imaging findings in corpus callosum region for the discrimination between opticospinal multiple sclerosis (osms) and neuromyelitis optica (nmo). |
2013-03-22 |
2023-08-12 |
Not clear |
| Shoufeng Jiang, Jiong Wu, Yi Yang, Jianren Liu, Yao Ding, Meiping Din. Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients. Molecular medicine reports. vol 6. issue 5. 2013-03-19. PMID:22895575. |
the present study aimed to compare the 2-dimensional (2d) electrophoresis pattern of the cerebrospinal fluid (csf) in multiple sclerosis (ms), neuromyelitis optica (nmo) and control individuals, to identify the proteins with differential expression and to examine their significance. |
2013-03-19 |
2023-08-12 |
Not clear |
| Peiqing Qian, Samantha Lancia, Enrique Alvarez, Eric C Klawiter, Anne H Cross, Robert T Naismit. Association of neuromyelitis optica with severe and intractable pain. Archives of neurology. vol 69. issue 11. 2013-03-14. PMID:22926050. |
to contrast differences in pain and treatment outcomes between neuromyelitis optica (nmo) and multiple sclerosis (ms). |
2013-03-14 |
2023-08-12 |
Not clear |
| Vishal Patel, Neil C Griffith, Emma Blackwood, Manu Dias, Dennis J Cordat. Spectrum disorder of neuromyelitis optica in a patient presenting with intractable vomiting and hiccups, transverse myelitis and acute encephalopathy. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. vol 19. issue 11. 2013-03-07. PMID:22925418. |
optic neuropathy and transverse myelitis (tm) are common symptoms of multiple sclerosis (ms) but may also be seen in association with the antibody-mediated autoimmune disorder, neuromyelitis optica (nmo). |
2013-03-07 |
2023-08-12 |
Not clear |
| Hiroshi Kuroda, Kazuo Fujihara, Rina Takano, Yoshiki Takai, Toshiyuki Takahashi, Tatsuro Misu, Ichiro Nakashima, Shigeru Sato, Yasuto Itoyama, Masashi Aok. Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica. Journal of neuroimmunology. vol 254. issue 1-2. 2013-02-25. PMID:23017732. |
complement is thought to play a pivotal role in neuromyelitis optica (nmo) pathogenesis. |
2013-02-25 |
2023-08-12 |
Not clear |
| Satoshi Yoshimura, Noriko Isobe, Takuya Matsushita, Tomomi Yonekawa, Katsuhisa Masaki, Shinya Sato, Yuji Kawano, Jun-ichi Kir. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status. Journal of neurology, neurosurgery, and psychiatry. vol 84. issue 1. 2013-02-22. PMID:23038741. |
to clarify whether genetic and common infectious backgrounds are distinct, according to anti-aquaporin 4 (aqp4) antibody status in japanese patients with neuromyelitis optica (nmo). |
2013-02-22 |
2023-08-12 |
Not clear |
| Ileana Benga, Oana Beng. Implications of water channel proteins in selected neurological disorders: epilepsies, muscular dystrophies, amyotrophic lateral sclerosis, neuromyelitis optica, Parkinson's disease, and spongiform encephalopathies. Molecular aspects of medicine. vol 33. issue 5-6. 2013-02-15. PMID:22484281. |
a typical example is neuromyelitis optica (nmo), in which the identification of the specific marker autoantibody against aquaporin 4 in the sera of patients was a milestone in the diagnosis. |
2013-02-15 |
2023-08-12 |
Not clear |
| Yan Xu, Yao Zhang, Cai-yan Liu, Bin Peng, Jian-ming Wang, Xiao-jun Zhang, Hai-feng Li, Li-ying Cu. Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity. Chinese medical journal. vol 125. issue 18. 2013-02-13. PMID:22964310. |
however, these studies did not include neuromyelitis optica (nmo) which might be proven to also have anti-mog antibody. |
2013-02-13 |
2023-08-12 |
Not clear |
| R Salazar, M Cerghet, E Farhat, H W Li. Neuromyelitis optica in a patient with pemphigus foliaceus. Journal of the neurological sciences. vol 319. issue 1-2. 2013-02-12. PMID:22632778. |
neuromyelitis optica (nmo, also eponymously known as devic's disease) is an immune-mediated demyelinating disease of the central nervous system that can lead to significant disability. |
2013-02-12 |
2023-08-12 |
Not clear |
| J W Lindsey, K M Meulmester, S A Brod, F Nelson, J S Wolinsk. Variable results after rituximab in neuromyelitis optica. Journal of the neurological sciences. vol 317. issue 1-2. 2013-02-11. PMID:22405926. |
our objective was to assess the efficacy of rituximab (rtx) in neuromyelitis optica (nmo). |
2013-02-11 |
2023-08-12 |
human |
| Mithu Storoni, Marcel M Verbeek, Zsolt Illes, Romain Marignier, Charlotte E Teunissen, Magda Grabowska, Christian Confavreux, Gordon T Plant, Axel Petzol. Serum GFAP levels in optic neuropathies. Journal of the neurological sciences. vol 317. issue 1-2. 2013-02-11. PMID:22410258. |
complement mediated autoimmunity against aquaporin-4 results in astrocytic damage in neuromyelitis optica (nmo). |
2013-02-11 |
2023-08-12 |
Not clear |
| Hsin-Ni Lin, Masanori Nagaoka, Yasuko Hayashi, Kozo Hator. Effect of vibration stimulation on dysbasia of spastic paraplegia in neuromyelitis optica: a possible example of neuronal plasticity. BMJ case reports. vol 2012. 2013-02-11. PMID:23045444. |
we analysed the effect of vibration stimulation (vs) on dysbasia of neuromyelitis optica (nmo). |
2013-02-11 |
2023-08-12 |
Not clear |
| Y Tomizawa, K Yokoyama, S Saiki, T Takahashi, J Matsuoka, N Hattor. Blood-brain barrier disruption is more severe in neuromyelitis optica than in multiple sclerosis and correlates with clinical disability. The Journal of international medical research. vol 40. issue 4. 2013-02-07. PMID:22971500. |
this study evaluated blood-brain barrier (bbb) integrity, using blood and cerebrospinal fluid (csf) markers, and assessed the practicality of these markers in the differential diagnosis of neuromyelitis optica (nmo) and multiple sclerosis (ms). |
2013-02-07 |
2023-08-12 |
Not clear |
| Hayrettin Tumani, Johannes Brettschneide. Biochemical markers of autoimmune diseases of the nervous system. Current pharmaceutical design. vol 18. issue 29. 2013-02-06. PMID:22612740. |
autoimmune neurological diseases associated with pathology of cell surface structures such as myasthenia gravis, lambert-eaton myasthenic syndrome, neuromyotonia, stiff person syndrome, limbic encephalitis, guillain-barré syndrome (gbs), and neuromyelitis optica (nmo) are amenable to serum antibody tests which can be used to support the diagnosis. |
2013-02-06 |
2023-08-12 |
Not clear |
| Paulus S Rommer, Robert Patejdl, Uwe K Zett. Monoclonal antibodies in the treatment of neuroimmunological diseases. Current pharmaceutical design. vol 18. issue 29. 2013-02-06. PMID:22612751. |
this article gives an overview on mab that are currently in use or under investigation for treating neuroimmunological diseases like multiple sclerosis (ms), neuromyelitis optica (nmo), chronic inflammatory demyelinating polyneuropathy (cidp), inclusion body myositis (ibm), dermatomyositis, polymyositis, opsoclonusmyoclonus syndrome (oms), multifocal motor neuropathy (mmn), anti-myelin-glycoprotein neuropathy (anti-mag), stiff person syndrome and myasthenia gravis (mg). |
2013-02-06 |
2023-08-12 |
Not clear |
| N Collongues, J B Chanson, F Blanc, J Steibel, C D Lam, A Shabbir, E Trifilieff, J Honnorat, D Pham-Dinh, M S Ghandour, J de Sez. The Brown Norway opticospinal model of demyelination: does it mimic multiple sclerosis or neuromyelitis optica? International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience. vol 30. issue 6. 2013-02-05. PMID:22634288. |
opticospinal demyelinating diseases in humans are mostly characterized by the opticospinal form of multiple sclerosis (ms) and neuromyelitis optica (nmo). |
2013-02-05 |
2023-08-12 |
rat |